These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 11836621

  • 1. IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells.
    Kozar K, Kaminski R, Giermasz A, Basak G, Zagozdzon R, Rybczynska J, Wasik M, Lasek W, Jakobisiak M, Golab J.
    Oncol Rep; 2002; 9(2):427-31. PubMed ID: 11836621
    [Abstract] [Full Text] [Related]

  • 2. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR, Renauld JC, Houssiau FA.
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [Abstract] [Full Text] [Related]

  • 3. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice.
    Lasek W, Golab J, Maśliński W, Switaj T, Bałkowiec EZ, Stokłosa T, Giermasz A, Malejczyk M, Jakóbisiak M.
    Eur Cytokine Netw; 1999 Sep; 10(3):345-56. PubMed ID: 10477391
    [Abstract] [Full Text] [Related]

  • 4. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E, Gunji Y, Herberman RB.
    J Immunol; 1988 Mar 15; 140(6):2096-102. PubMed ID: 3126240
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
    Mohan K, Moulin P, Stevenson MM.
    J Immunol; 1997 Nov 15; 159(10):4990-8. PubMed ID: 9366426
    [Abstract] [Full Text] [Related]

  • 6. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z.
    Mol Immunol; 2005 May 15; 42(9):1023-31. PubMed ID: 15829292
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells.
    Kawase I, Brooks CG, Kuribayashi K, Olabuenaga S, Newman W, Gillis S, Henney CS.
    J Immunol; 1983 Jul 15; 131(1):288-92. PubMed ID: 6408175
    [Abstract] [Full Text] [Related]

  • 8. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U.
    J Urol; 2000 Aug 15; 164(2):526-31. PubMed ID: 10893638
    [Abstract] [Full Text] [Related]

  • 9. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma.
    Page KM, Chaudhary D, Goldman SJ, Kasaian MT.
    J Leukoc Biol; 2008 May 15; 83(5):1267-76. PubMed ID: 18263766
    [Abstract] [Full Text] [Related]

  • 10. Soluble components of Hericium erinaceum induce NK cell activation via production of interleukin-12 in mice splenocytes.
    Yim MH, Shin JW, Son JY, Oh SM, Han SH, Cho JH, Cho CK, Yoo HS, Lee YW, Son CG.
    Acta Pharmacol Sin; 2007 Jun 15; 28(6):901-7. PubMed ID: 17506950
    [Abstract] [Full Text] [Related]

  • 11. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells.
    Haddad EA, Senger LK, Takei F.
    J Immunol; 2009 Sep 15; 183(6):3608-15. PubMed ID: 19710462
    [Abstract] [Full Text] [Related]

  • 12. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG, Garofalo AS, Travassos LR.
    Cytokines Cell Mol Ther; 2002 Sep 15; 7(3):107-16. PubMed ID: 12850810
    [Abstract] [Full Text] [Related]

  • 13. The role of reactive oxygen metabolites in the transcriptional regulation of IFN-gamma gene expression by histamine in NK cells following IL-2 stimulation.
    Houze TA, Larsson PA, Hellstrand K, Gustavsson B.
    Cell Biol Int; 1996 Sep 15; 20(9):589-98. PubMed ID: 8948120
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y, Uchida T, Inui T, Nakashima H, Fukasawa M, Seki S.
    Immunology; 2004 Sep 15; 113(1):35-43. PubMed ID: 15312134
    [Abstract] [Full Text] [Related]

  • 15. B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity.
    Alcón VL, Luther C, Balce D, Takei F.
    Eur J Immunol; 2009 Mar 15; 39(3):826-32. PubMed ID: 19197938
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
    Sabel MS, Arora A, Su G, Mathiowitz E, Reineke JJ, Chang AE.
    Surgery; 2007 Nov 15; 142(5):749-60. PubMed ID: 17981196
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L, Bracci M, Mocchegiani E.
    Int Immunopharmacol; 2006 Mar 15; 6(3):376-89. PubMed ID: 16428073
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-12 (IL-12) alone or in synergistic combination with IL-2 for in vitro activation of human bone marrow: differential effects at different time points.
    Verma UN, Mazumder A.
    Bone Marrow Transplant; 1995 Sep 15; 16(3):365-72. PubMed ID: 8535308
    [Abstract] [Full Text] [Related]

  • 19. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 15; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 20. Lytic activity of IL-2 and IL-12 stimulated NK cells against HOS osteosarcoma cell line.
    Mariani E, Tarozzi A, Meneghetti A, Tadolini M, Facchini A.
    Boll Soc Ital Biol Sper; 1996 Aug 15; 72(1-2):21-7. PubMed ID: 8868111
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.